in ,

VLP Therapeutics to Develop Malaria Vaccine Under Army Grant; Wataru Akahata Comments

VLP Therapeutics to Develop Malaria Vaccine Under Army Grant; Wataru Akahata Comments - top government contractors - best government contracting event
https://executivebiz-media.s3.amazonaws.com/2022/08/19/30/9f/c3/a0/b7/6f/d4/64/Executive-Biz.png

Health research managementVLP Therapeutics has received a $2.4 million grant from the U.S. Army to research and develop a vaccine against malaria.

The service branch awarded the research grant through the Defense Department’s Peer Reviewed Medical Research Program, the company said Thursday.

Wataru Akahata, founder and CEO of VLP Therapeutics, said the company has developed VLPM01, an experimental vaccine that works to home in on malaria parasite Plasmodium falciparum during its pre-erythrocytic stage.

Akahata added the firm has started preclinical trials of the vaccine candidate.

Gaithersburg, Maryland-based VLP Therapeutics is a biotechnology firm that aims to develop vaccines and antibody therapies for infectious diseases, cancer and other conditions through its inserted alphavirus virus-like particle technology platform, i-αVLP.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Products & Service

mm

Written by Jane Edwards

is a staff writer at Executive Mosaic, where she writes for ExecutiveBiz about IT modernization, cybersecurity, space procurement and industry leaders’ perspectives on government technology trends.

Mary Ann Hopkins: Parsons to Continue MDA Systems Engineering Support - top government contractors - best government contracting event
Mary Ann Hopkins: Parsons to Continue MDA Systems Engineering Support
NASA: Orbital ATK Eyes Aug. 22 Launch Date for Sixth ISS Cargo Resupply Mission - top government contractors - best government contracting event
NASA: Orbital ATK Eyes Aug. 22 Launch Date for Sixth ISS Cargo Resupply Mission